Cytochrome P450 17A1 Inhibitors

Name
Cytochrome P450 17A1 Inhibitors
Accession Number
DBCAT003461  (DBCAT004356)
Description
Not Available
Drugs
DrugDrug Description
AbirateroneAn antiandrogen used in the treatment of prostate cancer.
Drugs & Drug Targets
DrugTargetType
AbirateroneSteroid 17-alpha-hydroxylase/17,20 lyasetarget
AbirateroneSerum albumincarrier
AbirateroneAlpha-1-acid glycoprotein 1carrier
AbirateroneCytochrome P450 3A4enzyme
AbirateroneBile salt sulfotransferaseenzyme
AbirateroneMultidrug resistance-associated protein 1transporter
AbirateroneCytochrome P450 2D6enzyme
AbirateroneCytochrome P450 2C8enzyme
AbirateroneCytochrome P450 1A2enzyme
AbirateroneCytochrome P450 2C19enzyme
AbirateroneCytochrome P450 2C9enzyme